Product Information
ATAZANAVIR SULFATE 300 MG CAP is a generic product labeled by Aurobindo Pharma Limited, priced at $2.3086 per EA under NDC 65862071330. Its NADAC has been published 390 times since Aug 8, 2018.
FDA first approved this application on Jun 25, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862071330
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATAZANAVIR SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA204806FDA Approved
6/25/2018
TE Code
AB
On Market Since
6/25/2018
Pharmacological Classes
Price Statistics
The NADAC for ATAZANAVIR SULFATE 300 MG CAP has been published 390 times since Aug 8, 2018, and over the history we have for it it has declined 91.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3086 per EA |
|---|---|
| All-time high | $27.4533 (Aug 15, 2018) |
| All-time low | $1.7959 (Aug 21, 2024) |
| 52-week high | $3.3149 |
| 52-week low | $2.3086 |
| Median price | $5.9101 |
| Average price | $5.7947 |
| Largest weekly change | -43.2% (Sep 19, 2018) |
| Weeks tracked | 390 |
| Tracking since | Aug 8, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATAZANAVIR SULFATE 300 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for ATAZANAVIR SULFATE 300 MG CAP, manufactured by Aurobindo Pharma Limited, is $2.3086 per EA (NDC 65862071330), effective Aug 19, 2026.
How has the price of ATAZANAVIR SULFATE 300 MG CAP changed over time?
Over the history we have for it, the NADAC for ATAZANAVIR SULFATE 300 MG CAP has declined 91.6%. It has been tracked across 390 weekly CMS publications since Aug 8, 2018.
What are the highest and lowest recorded NADAC prices for ATAZANAVIR SULFATE 300 MG CAP?
Since Aug 8, 2018, the NADAC for ATAZANAVIR SULFATE 300 MG CAP has ranged from a low of $1.7959 (Aug 21, 2024) to a high of $27.4533 (Aug 15, 2018), with a median of $5.9101 per EA.
Are there cheaper alternatives to ATAZANAVIR SULFATE 300 MG CAP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATAZANAVIR SULFATE 300 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures ATAZANAVIR SULFATE 300 MG CAP?
ATAZANAVIR SULFATE 300 MG CAP (NDC 65862071330) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.